OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 98.8% based on the discounted cash flow analysis.
| Market cap | $8.33 Billion |
|---|---|
| Enterprise Value | $4.69 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.37 |
| Outstanding Shares | 302,220,000 |
| P/E Ratio | 18.79 |
|---|---|
| PEG | -7.27 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 5.09 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | 7.41 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8398▼ 23.32% |
|---|---|
| Total Calls | 13,279,400▲ 18.11% |
| Total Puts | 11,152,039▼ 7.56% |
Holdings and activity of institutional investors.
| Ownership % | 66.28%▲ 7.75% |
|---|---|
| Total Invested | $5.71B▲ 184.54% |
| Investors Holding | 443▲ 76.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...